Chinese Journal of Dermatology ›› 2017, Vol. 50 ›› Issue (10): 770-773.doi: 10.3760/cma.j.issn.0412-4030.2017.10.025
• Reviews • Previous Articles
Ying-Chun ZHANG1, Jian-Wei ZHU
Received:
2016-08-01
Revised:
2016-08-29
Online:
2017-10-15
Published:
2017-09-29
Contact:
Jian-Wei ZHU
E-mail:zjwmed@sina.com
Ying-Chun ZHANG Jian-Wei ZHU. Female pattern hair loss in clinic[J].Chinese Journal of Dermatology, 2017, 50(10): 770-773.
[1] | Shapiro J. Clinical practice. Hair loss in women[J]. N Engl J Med, 2007, 357(16): 1620⁃1630. DOI: 10.1056/NEJMcp072110. |
[2] | Sinclair R. Winding the clock back on female androgenetic alopecia[J]. Br J Dermatol, 2012, 166(6): 1157⁃1158. DOI: 10. 1111/j.1365⁃2133.2012.10934.x. |
[3] | Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities[J]. Br J Dermatol, 2010, 162(4): 843⁃847. DOI: 10.1111/j.1365⁃2133. 2010.09640.x. |
[4] | Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community⁃based survey[J]. J Am Acad Dermatol, 2013, 69(2): e69⁃77. DOI: 10.1016/j.jaad.2012.09.046. |
[5] | Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome[J]. Am J Clin Dermatol, 2007, 8(4): 201⁃219. DOI: 10.2165/00128071⁃200708040⁃00003. |
[6] | Kim BJ, Kim JY, Eun HC, et al. Androgenetic alopecia in adolescents: a report of 43 cases[J]. J Dermatol, 2006, 33(10): 696⁃699. DOI: 10.1111/j.1346⁃8138.2006.00161.x. |
[7] | Madnani N, Khan K, Chauhan P, et al. Polycystic ovarian syndrome[J]. Indian J Dermatol Venereol Leprol, 2013, 79(3): 310⁃321. DOI: 10.4103/0378⁃6323.110759. |
[8] | Dalamaga M, Papadavid E, Basios G, et al. Ovarian SAHA syndrome is associated with a more insulin⁃resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study[J]. J Am Acad Dermatol, 2013, 69(6): 922⁃930. DOI: 10.1016/j.jaad.2013.09.014. |
[9] | Arias⁃Santiago S, Gutiérrez⁃Salmerón MT, Buendía⁃Eisman A, et al. Sex hormone⁃binding globulin and risk of hyperglycemia in patients with androgenetic alopecia[J]. J Am Acad Dermatol, 2011, 65(1): 48⁃53. DOI: 10.1016/j.jaad.2010.05.002. |
[10] | Su LH, Chen LS, Lin SC, et al. Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease[J]. JAMA Dermatol, 2013, 149(5): 601⁃606. DOI: 10.1001/jamadermatol.2013.130. |
[11] | Yi SM, Son SW, Lee KG, et al. Gender⁃specific association of androgenetic alopecia with metabolic syndrome in a middle⁃aged Korean population[J]. Br J Dermatol, 2012, 167(2): 306⁃313. DOI: 10.1111/j.1365⁃2133.2012.10978.x. |
[12] | Abdel FNS, Darwish YW. Androgenetic alopecia and insulin resistance: are they truly associated?[J]. Int J Dermatol, 2011, 50(4): 417⁃422. DOI: 10.1111/j.1365⁃4632.2010.04677.x. |
[13] | Mahé YF, Michelet JF, Billoni N, et al. Androgenetic alopecia and microinflammation[J]. Int J Dermatol, 2000, 39(8): 576⁃584. DOI: 10.1046/j.1365⁃4362.2000.00612.x |
[14] | Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis[J]. Histopathology, 2010, 56(1): 24⁃38. DOI: 10.1111/j.1365⁃2559.2009.03439.x. |
[15] | Yazdan P. Update on the genetics of androgenetic alopecia, female pattern hair loss, and alopecia areata: implications for molecular diagnostic testing[J]. Semin Cutan Med Surg, 2012, 31(4): 258⁃266. DOI: 10.1016/j.sder.2012.08.003. |
[16] | Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness[J]. J Invest Dermatol, 2001, 116(3): 452⁃455. DOI: 10.1046/j.1523⁃1747.2001.01261.x. |
[17] | Li R, Brockschmidt FF, Kiefer AK, et al. Six novel susceptibility Loci for early⁃onset androgenetic alopecia and their unexpected association with common diseases[J]. PLoS Genet, 2012, 8(5):e1002746. DOI: 10.1371/journal.pgen.1002746. |
[18] | Redler S, Dobson K, Drichel D, et al. Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss[J]. J Dermatol Sci, 2013, 72(2): 186⁃188. DOI: 10.1016/j.jdermsci.2013.06.012. |
[19] | Heilmann S, Kiefer AK, Fricker N, et al. Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology[J]. J Invest Dermatol, 2013, 133(6): 1489⁃1496. DOI: 10.1038/jid.2013.43. |
[20] | Nuwaihyd R, Redler S, Heilmann S, et al. Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss[J]. Arch Dermatol Res, 2014, 306(4): 413⁃418. DOI: 10.1007/s00403⁃013⁃1436⁃4. |
[21] | Gatherwright J, Liu MT, Gliniak C, et al. The contribution of endogenous and exogenous factors to female alopecia: a study of identical twins[J]. Plast Reconstr Surg, 2012, 130(6): 1219⁃1226. DOI: 10.1097/PRS.0b013e31826d104f. |
[22] | Blume⁃Peytavi U, Blumeyer A, Tosti A, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents[J]. Br J Dermatol, 2011, 164(1): 5⁃15. DOI: 10.1111/j.1365⁃2133.2010.10011.x. |
[23] | Lee WS, Oh Y, Ji JH, et al. Analysis of familial factors using the basic and specific (BASP) classification in Korean patients with androgenetic alopecia[J]. J Am Acad Dermatol, 2011, 65(1): 40⁃47. DOI: 10.1016/j.jaad.2010.05.005. |
[24] | Lee WS, Lee HJ, Choi GS, et al. Guidelines for management of androgenetic alopecia based on BASP classification⁃⁃the Asian Consensus Committee guideline[J]. J Eur Acad Dermatol Venereol, 2013, 27(8): 1026⁃1034. DOI: 10.1111/jdv.12034. |
[25] | Gassmueller J, Rowold E, Frase T, et al. Validation of TrichoScan technology as a fully⁃automated tool for evaluation of hair growth parameters[J]. Eur J Dermatol, 2009, 19(3): 224⁃231. DOI: 10. 1684/ejd.2009.0640. |
[26] | Rasheed H, Mahgoub D, Hegazy R, et al. Serum ferritin and vitamin d in female hair loss: do they play a role?[J]. Skin Pharmacol Physiol, 2013, 26(2): 101⁃107. DOI: 10.1159/000346698. |
[27] | Kantor J, Kessler LJ, Brooks DG, et al. Decreased serum ferritin is associated with alopecia in women[J]. J Invest Dermatol, 2003, 121(5): 985⁃988. DOI: 10.1046/j.1523⁃1747.2003.12540.x. |
[28] | Malloy PJ, Feldman D. The role of vitamin D receptor mutations in the development of alopecia[J]. Mol Cell Endocrinol, 2011, 347(1⁃2): 90⁃96. DOI: 10.1016/j.mce.2011.05.045. |
[29] | Rebora A, Guarrera M. Kenogen. A new phase of the hair cycle?[J]. Dermatology, 2002, 205(2): 108⁃110. DOI: 10.1159/000063908. |
[30] | Sawaya ME, Blume⁃Peytavi U, Mullins DL, et al. Effects of finasteride on apoptosis and regulation of the human hair cycle[J]. J Cutan Med Surg, 2002, 6(1): 1⁃9. DOI: 10.1007/s10227⁃001⁃0024⁃y. |
[31] | Reid EE, Haley AC, Borovicka JH, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia[J]. J Am Acad Dermatol, 2012, 66(3): e97⁃102. DOI: 10.1016/j.jaad.2010.11. 042. |
[32] | Gupta AK, Daigle D. The use of low⁃level light therapy in the treatment of androgenetic alopecia and female pattern hair loss[J]. J Dermatolog Treat, 2014, 25(2): 162⁃163. DOI: 10.3109/09546634.2013.832134. |
No related articles found! |
|